Panacea Biotec eyes $1 billion hexavalent vaccinemarket
Panacea hopes to get the World Health Organization's prequalification by early 2022.Panacea's hexavalent vaccine can immunize patients against six diseases29-12-2019
29-12-2019
Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our letter dated December 27, 2019 along with Notice of Hon'ble National Company Law Tribunal Convened Meeting of Equity Shareholders and pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith newspaper copies of the notice of aforesaid meeting published in the following newspapers on December 28, 2019:- Business Standard (English); Desh Sewak (Punjabi)28-12-2019
Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our letter dated December 27, 2019 along with Notice of Hon'ble National Company Law Tribunal Convened Meeting of Unsecured Creditors and pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith newspaper copies of the notice of aforesaid meeting published in the following newspapers on December 28, 2019:- Business Standard (English); Desh Sewak (Punjabi)28-12-2019
PANACEA BIOTEC LTD. - 531349 - Notice Of Hon'Ble National Company Law Tribunal Convened Meeting Of Unsecured Creditors Scheduled To Be Held On January 28, 2020 At 2:00 P.M.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the Notice of the Hon'ble National Company Law Tribunal ('NCLT') Convened Meeting of the unsecured creditors of the Company, scheduled to be held on Tuesday, January 28, 2020 at 02:00 P.M. at the Registered Office of the Company at Ambala-Chandigarh Highway, Lalru, Punjab-140501, in terms of the directions given by Hon''ble NCLT, Chandigarh Bench, vide its order dated December 13, 2019, for the purpose of considering, and if thought fit, approving the Scheme of Arrangement amongst Panacea Biotec Limited ('Demerged Company') and Ravinder Heights Limited ('Resulting Company') and their respective shareholders and creditors ('Scheme of Arrangement') for demerger of Real Estate Business of the Demerged Company ('Demerged Undertaking', more particularly defined in the Scheme) with and into Resulting Company.27-12-2019
PANACEA BIOTEC LTD. - 531349 - Notice Of Hon'Ble National Company Law Tribunal Convened Meeting Of Equity Shareholders Scheduled To Be Held On January 28, 2020 At 11:00 A.M. And Details Of Cut-Off Date For E-Voting And E-Voting Period
Pursuant to Reg 30 of SEBI LODR Regulations, 2015, please find enclosed herewith a copy of the Notice of the Hon'ble NCLT Convened Meeting of the equity shareholders of the Company, scheduled to be held on Tuesday, 28.01.2020 at 11:00 A.M. at the Registered Office of the Company, for the purpose of considering, and if thought fit, approving the Scheme of Arrangement. Further, the Company has also provided the facility to its equity shareholders to cast their votes either by way of remote e-voting facility prior to the meeting or by way of voting at the venue of the meeting through ballot paper in connection with the resolution proposed to be passed in terms of the aforesaid Notice. Further, you are also requested to take on record the following: 1.The cut-off date for the purpose of exercising remote e-voting facility shall be 30.06.2019. 2.The remote e-voting period shall commence on Sunday, 29.12.2019 (from 09:00 a.m. IST) and end on Monday, 27.01.2020 (upto 05:00 p.m. IST).27-12-2019
Panacea Biotec share price jumps 11% on $24 million order
"UNICEF award is for calendar year 2020 and award of PAHO is for three calendar years i.e. 2020-2022," company said in its BSE filing.19-12-2019
Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release - Panacea Biotec receives USD 24.32 Million Award of Pentavalent Vaccine from U.N. Agencies Panacea Biotec Ltd. is pleased to announce that the company has received Awards worth USD 24.32 Million (Over INR 170 Crores) from U.N. Agencies (UNICEF and PAHO) for supply of its Easyfive-TT, a fully liquid WHO prequalified wP based Pentavalent Vaccine (DTwP-HepB-Hib). A copy of the Press Release being issued to the media, etc. in this regard is enclosed for your kind reference and record please.19-12-2019
PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release - Panacea Biotec receives USD 24.32 Million Award of Pentavalent Vaccine from U.N. Agencies Panacea Biotec Ltd. is pleased to announce that the company has received Awards worth USD 24.32 Million (Over INR 170 Crores) from U.N. Agencies (UNICEF and PAHO) for supply of its Easyfive-TT, a fully liquid WHO prequalified wP based Pentavalent Vaccine (DTwP-HepB-Hib). A copy of the Press Release being issued to the media, etc. in this regard is enclosed for your kind reference and record please.19-12-2019
CPPIB invests $225m in Piramal-Bain stressed asset JV
So far, the platform has invested more than $300 million in India across three investments in Panacea Biotec, Archean Chemicals and Indian Steel Corp18-12-2019
Panacea Biotec Ltd - 531349 - Disclosure Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosures of related party transactions in the format specified in the relevant accounting standards for half year ended September 30, 2019 on consolidated basis. This is for your kind information and record please.13-12-2019